1505, 2019
Are Cannabinoid-Derived Drugs the Future of Medicine?
Less than a year ago, [...]
805, 2019
The Power of Patient Registries: How to Collaborate with Patients to Enhance Orphan Drug Research
Each year, doctors diagnose about 1,000 [...]
105, 2019
Is Gut Microbiome Behind Our Next Breakthrough Therapy?
"Microbiome" has become a consumer product [...]
2404, 2019
Patient Recruitment Solution: How to Ease Fear of the Unknown in Clinical Trials
The numbers vary but multiple surveys [...]
1804, 2019
Cellular Therapy in Neurological Diseases: The Latest Advances and Challenges
Neurological disorders and diseases affect all [...]
1704, 2019
Advances in Non-Opioid Options for Post-Operative Pain Management
In a statement last August, departing [...]
404, 2019
Introducing Biorasi’s Center of Excellence: Neurology and Regenerative Medicine
Advances in stroke management, the first [...]
2703, 2019
When Virtual Trials Are Not the Answer
Business as usual is not an option for conducting #clinicaltrials in the wake of the #COVID19 pandemic. Customized solutions and #patientcentricity are more optimal approaches in this environment. Jimmy El Hokayem, Ph.D., Associate Director of Program Development and Head of the Neurology and Regenerative Medicine Center of Excellence at Biorasi, shares his insights into #directtopatienttrials
